We used flow cytometry to analyse the tumour infiltrate of broad immune cell groups of B (CD19 +) and T cell (CD3+, CD4+, CD8+) lymphocytes, and myeloid cells (CD11b+, CD11c +) in a subset of the tumours (Additional file 1) from Fig. 5a. The gene discussed is CD19; the disease is neoplasm.